Flannelly G, Jiang G, Anderson D, Melvin W, Mann E, Kitchener H
Wellbeing Centre for the Prevention of Cervical Cancer, Aberdeen Royal Infirmary, University of Aberdeen, Scotland.
J Med Virol. 1995 Sep;47(1):6-9. doi: 10.1002/jmv.1890470103.
The aim of this study was to examine the efficacy of semi-quantitative polymerase chain reaction (PCR) testing in cervical smears as an adjunct to cytological surveillance in a cohort of women with mild or moderate dyskaryosis. The study population comprised a group of 62 women who underwent twelve months of cytological and colposcopic surveillance as part of a larger randomised prospective study of women with mild and moderate dyskaryosis. Semi-quantitative PCR for HPV-16 DNA was carried out on the initial and twelve month study smears before a large loop excision of the transformation zone (LLETZ) was carried out. Smears from a control population which comprised 167 women without a history of abnormal cervical cytology who were attending family planning and general practitioner clinics for routine cervical smears were tested similarly. The presence of high or intermediate levels of HPV-16 DNA on both the initial and twelve month study smear was positively associated with the identification of cervical intraepithelial neoplasia (CIN) grades II or III in the LLETZ specimen (P = 0.01). While the combination of HPV-16 DNA testing with cytology on a repeat cervical smear improved the selection of women with underlying CIN II/III, there was still a false negative rate of 53%. Twenty-nine women had 'low risk' levels of HPV-16 DNA and mild dyskaryosis or less on both repeat smears indicating suitability for surveillance, but in fact 34% of them had CIN II/III. This study supports the finding reported previously of an association between high and intermediate levels of HPV-16 DNA and CIN II/III.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是检验在一组患有轻度或中度核异质的女性中,宫颈涂片的半定量聚合酶链反应(PCR)检测作为细胞学监测辅助手段的有效性。研究人群包括62名女性,她们作为一项针对轻度和中度核异质女性的更大规模随机前瞻性研究的一部分,接受了为期十二个月的细胞学和阴道镜监测。在进行转化区大环形切除术(LLETZ)之前,对初始研究涂片和十二个月研究涂片进行了HPV-16 DNA的半定量PCR检测。对来自对照组人群的涂片进行了类似检测,该对照组包括167名无宫颈细胞学异常病史、因常规宫颈涂片而前往计划生育诊所和全科医生诊所就诊的女性。初始研究涂片和十二个月研究涂片上均存在高水平或中等水平的HPV-16 DNA,与LLETZ标本中宫颈上皮内瘤变(CIN)II级或III级的检出呈正相关(P = 0.01)。虽然在重复宫颈涂片上进行HPV-16 DNA检测与细胞学检查相结合,改善了对潜在CIN II/III女性的筛选,但仍有53%的假阴性率。29名女性在两次重复涂片上HPV-16 DNA水平为“低风险”且核异质为轻度或更低,表明适合进行监测,但实际上其中34%患有CIN II/III。本研究支持先前报道的HPV-16 DNA高水平和中等水平与CIN II/III之间存在关联的发现。(摘要截短于250字)